tradingkey.logo
tradingkey.logo
Pesquisar

ReShape Lifesciences Inc

RSLS
Adicionar à lista de desejos
3.920USD
0.0000.00%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
10.29MValor de mercado
PerdaP/L TTM

Mais detalhes de ReShape Lifesciences Inc Empresa

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Informações de ReShape Lifesciences Inc

Código da empresaRSLS
Nome da EmpresaReShape Lifesciences Inc
Data de listagemOct 06, 2016
CEOMr. Paul F. Hickey
Número de funcionários17
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 06
Endereço1001 Calle Amanecer
CidadeSAN CLEMENTE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92673
Telefone19494296680
Sitehttps://www.reshapelifesciences.com/obalon/
Código da empresaRSLS
Data de listagemOct 06, 2016
CEOMr. Paul F. Hickey

Executivos da empresa ReShape Lifesciences Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de ReShape Lifesciences Inc?

Os cinco principais acionistas de ReShape Lifesciences Inc são: Mr. Krishna Gupta

Quantas instituições possuem ações da ReShape Lifesciences Inc (RSLS)?

Em 2026Q1, 34 instituições possuíam ações da ReShape Lifesciences Inc, com valor de mercado aproximado de 207.69K, representando 2.96% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 148618.00.